首页|Estrogen receptor beta suppresses the androgen receptor oncogenic effects in triple-negative breast cancer

Estrogen receptor beta suppresses the androgen receptor oncogenic effects in triple-negative breast cancer

扫码查看

Androgen receptorEstrogen receptor betaTriple-negative breast cancerNECTIN4Oncogenic effectsTumor progression

Xu Feng、Xu Kun、Fan Lingling、Li Xintong、Liu Yiqiu、Yang Fang、Zhu Chengjun、Guan Xiaoxiang、Gao Ting、Hao Xiuyuan

展开 >

Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China

The Comprehensive Cancer Center of Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu 210008, China

4Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing Medical University, Nanjing, Jiangsu 211166, China

Androgen receptor Estrogen receptor beta Triple-negative breast cancer NECTIN4 Oncogenic effects Tumor progression

Key International Cooperation of the National Natural Science Foundation of ChinaKey Foundation for Social Development Project of the Jiangsu Province, ChinaYouth Fund of the National Natural Science Foundation of China

81920108029BE202174182002783

2024

中华医学杂志(英文版)
中华医学会

中华医学杂志(英文版)

CSTPCD
影响因子:0.838
ISSN:0366-6999
年,卷(期):2024.137(3)
  • 40